Is Wellbutrin (bupropion) associated with muscle toxicity?

Is Wellbutrin Muscle Toxic?

Wellbutrin (bupropion) is not typically muscle toxic at therapeutic doses, but rhabdomyolysis has been documented in overdose situations, particularly when combined with other drugs. 1

Muscle Toxicity in Overdose

The FDA label explicitly states that fever, muscle rigidity, and rhabdomyolysis have been reported mainly when bupropion was part of multiple drug overdoses. 1 This indicates that muscle toxicity is not a characteristic feature of bupropion alone but rather emerges in the context of:

• Massive overdoses (up to 30 grams or more reported) 1
• Polypharmacy overdoses where bupropion is combined with other substances 1
• Severe systemic toxicity including hypotension, stupor, coma, and respiratory failure 1

Movement Disorders vs. Direct Muscle Toxicity

While bupropion does not cause direct muscle toxicity at therapeutic doses, it can produce movement-related adverse effects that should not be confused with myotoxicity:

Myoclonus and Muscle Jerking

• Myoclonus (involuntary muscle jerking) has been reported, particularly with dose escalation 2
• In one case series, bupropion-induced myoclonus fully resolved within 24 hours of discontinuation in most patients 2
• Upper extremity myoclonic jerks and facial twitching have been documented 2, 3

Dystonia and Muscle Rigidity

• Acute dystonia (neck stiffness, trismus, jaw muscle tightness) can occur with dose increases 4
• These symptoms show a dose-response relationship and resolve with dose reduction 4
• Muscle rigidity in overdose contexts is part of a broader toxidrome, not isolated muscle toxicity 1

Tremor

• Tremor is a recognized adverse effect, occurring in 6% of patients on 300 mg/day 1
• This is a neurologic effect, not evidence of muscle damage 1

Therapeutic Dose Safety Profile

At recommended therapeutic doses, bupropion does not cause muscle toxicity. 5, 6 The most common adverse effects are:

• Neuropsychiatric: insomnia, anxiety, agitation 5, 1
• Gastrointestinal: nausea, constipation 5
• Autonomic: sweating, tachycardia 1

Notably absent from therapeutic dose adverse effect profiles are rhabdomyolysis, myopathy, or elevated creatine kinase. 5, 6

Clinical Implications

When to Suspect Bupropion-Related Muscle Issues

Suspect overdose-related rhabdomyolysis if:

• Patient presents with known or suspected massive ingestion 1
• Multiple uncontrolled seizures are present (seizures themselves can cause rhabdomyolysis) 1
• Fever and muscle rigidity develop in the context of polypharmacy overdose 1

Monitoring Recommendations

For therapeutic dosing:

• No routine muscle enzyme monitoring is required 5, 6
• Monitor for movement disorders (myoclonus, tremor, dystonia) which are reversible 2, 4

For overdose situations:

• Check creatine kinase if rhabdomyolysis is suspected 1
• Provide supportive care with close medical supervision 1
• Monitor renal function if rhabdomyolysis develops 1

Key Distinction

The critical distinction is between reversible neurologic movement disorders (common) and true muscle toxicity/rhabdomyolysis (rare, overdose-related). 1, 2, 4 Movement abnormalities like myoclonus and tremor reflect bupropion's effects on dopaminergic and noradrenergic pathways, not direct muscle damage. 2, 4